Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Company research

Bodhi Tree Biotechnology Inc

CIK 2041531Updated Sep 27, 2026

SecurityBDTB · OTC · equity

BDTB price & chart

Provider market data

Loading TradingView…

OTC:BDTB on TradingView ↗

TradingView · Data may be delayed

In the news

No coverage from other publishers is available.

Recent filings

  1. 10-Q filing

    10-Q · 2026-08-14 · 0001829126-26-008876

  2. 10-Q filing

    10-Q · 2026-05-14 · 0001829126-26-005192

  3. 10-Q filing

    10-Q · 2026-02-13 · 0001829126-26-001338

  4. 10-K filing

    10-K · 2025-12-29 · 0001829126-25-010312

  5. 10-Q filing

    10-Q · 2025-08-12 · 0001829126-25-006136

Show 5 more recent filings

  1. 10-Q/A filing

    10-Q/A · 2025-07-28 · 0001829126-25-005460

  2. Other Events

    Items 8.01

    8-K · 2025-06-06 · 0001829126-25-004279

  3. D/A filing

    D/A · 2025-06-05 · 0001829126-25-004271

  4. 10-Q filing

    10-Q · 2025-05-20 · 0001829126-25-003834

  5. NT 10-Q filing

    NT 10-Q · 2025-05-14 · 0001829126-25-003659

Financials

FY 2025 · USD
Net income-149,666USD · FY 2025
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Cash— · FY 2025
Operating income-147,618USD · FY 2025
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Diluted EPS-0.01USD per share · FY 2025
Source

10-Q · 2026-02-13 · 0001829126-26-001338

2025-10-01 to 2025-12-31

Some figures are unavailable for this reporting year.

balance sheet · annual statements
Line itemFY 2025
ASSETS
AssetsUSD119,161
Source

10-K · 2025-12-29 · 0001829126-25-010312

As of 2025-09-30

LIABILITIES AND EQUITY
Stockholders’ equity:
Common Stock, Value, IssuedUSD2,544
Source

10-Q · 2026-02-13 · 0001829126-26-001338

As of 2025-12-31

Additional Paid in CapitalUSD328,236
Source

10-Q · 2026-02-13 · 0001829126-26-001338

As of 2025-12-31

Retained Earnings (Accumulated Deficit)USD-211,619
Source

10-K · 2025-12-29 · 0001829126-25-010312

As of 2025-09-30

Stockholders' Equity Attributable to ParentUSD119,161
Source

10-K · 2025-12-29 · 0001829126-25-010312

As of 2025-09-30

Liabilities and EquityUSD119,161
Source

10-K · 2025-12-29 · 0001829126-25-010312

As of 2025-09-30

Lines labelled “Derived” are calculated from reported figures.

cash flow · annual statements
Line itemFY 2025
Cash flows from operating activities:
Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD-149,666
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Net Cash Provided by (Used in) Operating ActivitiesUSD-150,166
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD109,404
Source

10-K · 2025-12-29 · 0001829126-25-010312

As of 2025-09-30

Additional Financial Items
General and Administrative ExpenseUSD164,618
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Income Tax Expense (Benefit)USD2,050
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Net Income (Loss) Attributable to ParentUSD-149,666
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Other Nonoperating Income (Expense)USD2
Source

10-Q · 2026-05-14 · 0001829126-26-005192

2025-10-01 to 2026-03-31

Lines labelled “Derived” are calculated from reported figures.

income statement · annual statements
Line itemFY 2025
Total RevenueUSD17,000
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Operating Income (Loss)USD-147,618
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Other Nonoperating Income (Expense)USD2
Source

10-Q · 2026-05-14 · 0001829126-26-005192

2025-10-01 to 2026-03-31

Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD-147,616
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Income Tax Expense (Benefit)USD2,050
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Net Income (Loss) Attributable to ParentUSD-149,666
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Earnings Per Share, BasicUSD per share-0.01
Source

10-Q · 2026-02-13 · 0001829126-26-001338

2025-10-01 to 2025-12-31

Earnings Per Share, DilutedUSD per share-0.01
Source

10-Q · 2026-02-13 · 0001829126-26-001338

2025-10-01 to 2025-12-31

Weighted Average Number of Shares Outstanding, Basicshares25,441,042
Source

10-Q · 2026-02-13 · 0001829126-26-001338

2025-10-01 to 2025-12-31

Weighted Average Number of Shares Outstanding, Dilutedshares25,441,042
Source

10-Q · 2026-02-13 · 0001829126-26-001338

2025-10-01 to 2025-12-31

Additional Financial Items
General and Administrative ExpenseUSD164,618
Source

10-K · 2025-12-29 · 0001829126-25-010312

2024-10-01 to 2025-09-30

Interest Income (Expense), NetUSD2
Source

10-Q · 2026-05-14 · 0001829126-26-005192

2025-10-01 to 2026-03-31

Lines labelled “Derived” are calculated from reported figures.

Offerings

Registration 333-284678

S-1/A · 2025-02-21 · 0001829126-25-001164

Terms from the governing filing for this registration; not a claim that the offering is open today.